Local gene knockdown in the brain using viral-mediated RNA interference
- PMID: 14634645
- DOI: 10.1038/nm964
Local gene knockdown in the brain using viral-mediated RNA interference
Abstract
Conditional mutant techniques that allow spatial and temporal control over gene expression can be used to create mice with restricted genetic modifications. These mice serve as powerful disease models in which gene function in adult tissues can be specifically dissected. Current strategies for conditional genetic manipulation are inefficient, however, and often lack sufficient spatial control. Here we use viral-mediated RNA interference (RNAi) to generate a specific knockdown of Th, the gene encoding the dopamine synthesis enzyme tyrosine hydroxylase, within midbrain neurons of adult mice. This localized gene knockdown resulted in behavioral changes, including a motor performance deficit and reduced response to a psychostimulant. These results underscore the potential of using viral-mediated RNAi for the rapid production and testing of new genetic disease models. Similar strategies may be used in other model species, and may ultimately find applications in human gene therapy.
Similar articles
-
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17270-5. doi: 10.1073/pnas.0406214101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569935 Free PMC article.
-
Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.Biol Psychiatry. 2007 Jan 1;61(1):65-9. doi: 10.1016/j.biopsych.2006.03.020. Epub 2006 May 19. Biol Psychiatry. 2007. PMID: 16712807
-
Simultaneous Cre-mediated conditional knockdown of two genes in mice.Genesis. 2008 Mar;46(3):144-51. doi: 10.1002/dvg.20376. Genesis. 2008. PMID: 18327788
-
Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.Pharmacol Ther. 2007 Mar;113(3):619-34. doi: 10.1016/j.pharmthera.2006.12.003. Epub 2007 Jan 10. Pharmacol Ther. 2007. PMID: 17289150 Review.
-
Animal transgenesis: an overview.Brain Struct Funct. 2010 Mar;214(2-3):91-109. doi: 10.1007/s00429-009-0230-8. Epub 2009 Nov 25. Brain Struct Funct. 2010. PMID: 19937345 Review.
Cited by
-
Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.Proc Natl Acad Sci U S A. 2013 May 14;110(20):8254-9. doi: 10.1073/pnas.1214696110. Epub 2013 Apr 29. Proc Natl Acad Sci U S A. 2013. PMID: 23630294 Free PMC article.
-
Therapeutic gene silencing in neurological disorders, using interfering RNA.J Mol Med (Berl). 2005 Jun;83(6):413-9. doi: 10.1007/s00109-005-0649-1. Epub 2005 Mar 10. J Mol Med (Berl). 2005. PMID: 15759100 Review.
-
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17270-5. doi: 10.1073/pnas.0406214101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569935 Free PMC article.
-
Osteocalcin in the brain: from embryonic development to age-related decline in cognition.Nat Rev Endocrinol. 2018 Mar;14(3):174-182. doi: 10.1038/nrendo.2017.181. Epub 2018 Jan 29. Nat Rev Endocrinol. 2018. PMID: 29376523 Free PMC article. Review.
-
Glycogen synthase kinase 3 beta alters anxiety-, depression-, and addiction-related behaviors and neuronal activity in the nucleus accumbens shell.Neuropharmacology. 2017 May 1;117:49-60. doi: 10.1016/j.neuropharm.2017.01.020. Epub 2017 Jan 23. Neuropharmacology. 2017. PMID: 28126496 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources